'Blood cancer drugs market' presentation slideshows

Global Oncology/Cancer Drugs Market (Therapeutic Modalities,

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market

347 views • 11 slides

Oncology/Cancer Drugs Market - Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity.

395 views • 11 slides

Global Oncology/Cancer Drugs Market Growth 2013-2020

372 views • 10 slides